A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors
Clinical trial NCT03503604 · UNKNOWN
Trial details
- NCT number
- NCT03503604
- Sponsor
- SuZhou Stainwei Biotech Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2019-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.